arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Teladoc Health, Inc.

TDOC
$9.42 ▼ -0.27 (-2.79%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
14 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

Teladoc Health, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B
Dividend Yield —
Revenue Growth -1.5% ↘
Op. Margin -10.4% ↗
ROIC -16.1% ↗
FCF / Share $1.62 ↘
Trailing P/E —
Price / Book 1.2x
FCF Yield 17.2%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.53B
↓ -1.5% —
Net Income Profit after all expenses
$-200.32M
↑ +80.0% —
Operating Margin Operating profit as % of sales
-10.4%
↑ +73.8% 15th
FCF / Share Free cash flow per share
$1.62
↓ -2.3% —
Long-Term Debt Long-term obligations
$44.42M
↑ +67.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
33
Returns ↓
31
Cash Quality ↓
8

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 53 quarters